Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| FiscalNote Holdings Inc (Class A) | Manoj Jain | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 17 Jan 2023 | 7,000,000 | 0 | - | - | Warrants (Right to Buy) | |
| FiscalNote Holdings Inc (Class A) | Manoj Jain | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 17 Jan 2023 | 4,138,400 | 4,138,400 | - | - | Warrants (Right to Buy) | |
| Scilex Holding Co | Jaisim Shah | Director, See Remarks | 17 Jan 2023 | 1,700,000 | 1,700,000 | - | - | Nonstatutory Stock Option (right to buy) | ||
| FiscalNote Holdings Inc (Class A) | Manoj Jain | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 17 Jan 2023 | 1,593,900 | 1,593,900 | - | - | Warrants (Right to Buy) | |
| Energy Focus Inc | Mei Yun Gina Huang | Director, Ten Percent Owner | 17 Jan 2023 | 1,451,597 | 2,417,030 (15%) | 9% | 0.6 | 817,249 | Common Stock | |
| FiscalNote Holdings Inc (Class A) | Manoj Jain | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 17 Jan 2023 | 1,267,700 | 1,267,700 | - | - | Warrants (Right to Buy) | |
| BARK Inc (Class A) | Zahir Ibrahim | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 750,000 | 750,000 | - | - | Stock Option (right to buy) | |
| BARK Inc (Class A) | Zahir Ibrahim | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 750,000 | 750,000 | - | 0 | Common Stock | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 701,680 | 701,680 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 701,680 | 701,680 | - | - | Stock Option (Right to Buy) | |
| Johnson & Johnson | Alex Gorsky | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 547,692 | 0 | - | - | Employee Stock Options (Right to Buy) | |
| Johnson & Johnson | Alex Gorsky | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.54 per share. | 17 Jan 2023 | 547,692 | 1,133,193 (0%) | 0% | 72.5 | 39,729,578 | Common Stock |
| Acumen Pharma Inc | Daniel O'Connell | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 472,500 | 472,500 | - | - | Employee Stock Option (right to buy) | |
| Kinder Morgan (Class P) | Martin A. Thomas | V.P. (Pres.,Nat.Gas Pipelines) | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 382,572 | 382,572 | - | - | Restricted Stock Unit | |
| Johnson & Johnson | Alex Gorsky | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 173.43 per share. | 17 Jan 2023 | 366,610 | 766,583 (0%) | 0% | 173.4 | 63,581,172 | Common Stock |
| Scilex Holding Co | Elizabeth A. Czerepak | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 350,000 | 350,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Ventyx Biosciences Inc | Raju S. Mohan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 284,250 | 284,250 | - | - | Stock Option (Right to Buy) | |
| Cellectar Biosciences Inc | James V. Caruso | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 261,000 | 261,000 | - | - | Stock option (right to buy) | |
| Insight Molecular Diagnostics Inc | Joshua Riggs | Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 257,485 | 257,485 | - | - | Option to Purchase Common Stock | |
| Insight Molecular Diagnostics Inc | Anish John | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 250,466 | 250,466 | - | - | Option to Purchase Common Stock | |
| Scilex Holding Co | Tien-Li Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 250,000 | 250,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Scilex Holding Co | Dorman Followwill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 250,000 | 250,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Scilex Holding Co | David Jakob Lemus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 250,000 | 250,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Scilex Holding Co | Laura J. Hamill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 250,000 | 250,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Scilex Holding Co | Tommy G. Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 250,000 | 250,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Day One Biopharma Inc | Jeremy Bender | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 244,000 | 244,000 | - | - | Stock Option (right to buy Common Stock) | |
| Archer Aviation Inc (Class A) | Brett Adcock | Ten Percent Owner | 17 Jan 2023 | 217,000 | 23,569,278 | - | - | Class B Common Stock | ||
| Archer Aviation Inc (Class A) | Brett Adcock | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.04 per share. | 17 Jan 2023 | 217,000 | 0 | - | 3.0 | 658,899 | Class A Common Stock |
| Archer Aviation Inc (Class A) | Brett Adcock | Ten Percent Owner | 17 Jan 2023 | 217,000 | 217,000 | - | - | Class A Common Stock | ||
| Nine Energy Service Inc | Warren Lynn Frazier | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.12 per share. | 17 Jan 2023 | 215,772 | 2,903,315 (9%) | 0% | 4.1 | 888,657 | Common Stock |
| Archer Aviation Inc (Class A) | Brett Adcock | Ten Percent Owner | 17 Jan 2023 | 200,000 | 200,000 | - | - | Class A Common Stock | ||
| Archer Aviation Inc (Class A) | Brett Adcock | Ten Percent Owner | 17 Jan 2023 | 200,000 | 23,786,278 | - | - | Class B Common Stock | ||
| Archer Aviation Inc (Class A) | Brett Adcock | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.57 per share. | 17 Jan 2023 | 200,000 | 0 | - | 2.6 | 514,060 | Class A Common Stock |
| ChargePoint Holdings Inc (Class A) | Eric Sidle | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 193,232 | 0 | - | - | Stock Option (right to buy) | |
| ChargePoint Holdings Inc (Class A) | Eric Sidle | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.56 per share. | 17 Jan 2023 | 193,232 | 830,302 | - | 0.6 | 108,210 | Common Stock |
| Prologis | Hamid R. Moghadam | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 160,708 | 1,669,858 | - | - | LTIP Units | |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 160,390 | 160,390 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 160,390 | 246,276 | - | 0 | Common Stock | |
| Relay Therapeutics Inc | Donald A. Bergstrom | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 160,390 | 160,390 | - | - | Stock Option (Right to Buy) | |
| ADT Inc | Daniel M. Bresingham | EVP, Commercial | Sale of securities on an exchange or to another person at price $ 9.60 per share. | 17 Jan 2023 | 157,959 | 1,776,114 (0%) | 0% | 9.6 | 1,516,406 | Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Jason Kelly | Director, See remarks | Sale of securities on an exchange or to another person at price $ 1.95 per share. | 17 Jan 2023 | 154,796 | 15,917,987 | - | 2.0 | 302,162 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Reshma P. Shetty | Director, See remarks, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.95 per share. | 17 Jan 2023 | 154,796 | 16,342,700 | - | 2.0 | 302,162 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Reshma P. Shetty | Director, See remarks, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.95 per share. | 17 Jan 2023 | 154,795 | 16,305,060 | - | 2.0 | 302,160 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Jason Kelly | Director, See remarks | Sale of securities on an exchange or to another person at price $ 1.86 per share. | 17 Jan 2023 | 151,531 | 16,172,783 | - | 1.9 | 282,454 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Reshma P. Shetty | Director, See remarks, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.86 per share. | 17 Jan 2023 | 151,531 | 16,497,496 | - | 1.9 | 282,454 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Reshma P. Shetty | Director, See remarks, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.86 per share. | 17 Jan 2023 | 151,530 | 16,497,505 | - | 1.9 | 282,452 | Class A Common Stock |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 148,538 | 0 | - | - | Employee Stock Options (Right to Buy) | |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.54 per share. | 17 Jan 2023 | 148,538 | 394,515 (0%) | 0% | 72.5 | 10,774,947 | Common Stock |
| Charter (Class A) | Thomas M. Rutledge | Director, Executive Chairman | 17 Jan 2023 | 147,905 | 147,905 | - | - | Stock Options | ||
| Charter (Class A) | Thomas M. Rutledge | Director, Executive Chairman | 17 Jan 2023 | 147,905 | 0 | - | - | Stock Options | ||
| Cellectar Biosciences Inc | Jarrod Longcor | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 144,000 | 144,000 | - | - | Stock option (right to buy) | |
| Greif Inc (Class A) | Peter G. Watson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 139,653 | 384,483 (1%) | 0% | 0 | Class A Common Stock | |
| Charter (Class A) | Thomas M. Rutledge | Director, Executive Chairman | 17 Jan 2023 | 136,188 | 136,188 | - | - | Stock Options | ||
| Charter (Class A) | Thomas M. Rutledge | Director, Executive Chairman | 17 Jan 2023 | 136,188 | 0 | - | - | Stock Options | ||
| Tenaya Therapeutics Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.52 per share. | 17 Jan 2023 | 135,688 | 9,800,535 | - | 2.5 | 341,432 | Common Stock |
| Coca-Cola | Brian J. Smith | Senior Executive | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.61 per share. | 17 Jan 2023 | 126,972 | 243,140 (0%) | 0% | 37.6 | 4,775,417 | Common Stock, $.25 Par Value |
| Coca-Cola | Brian J. Smith | Senior Executive | Sale of securities on an exchange or to another person at price $ 62.07 per share. | 17 Jan 2023 | 126,972 | 116,168 (0%) | 0% | 62.1 | 7,881,317 | Common Stock, $.25 Par Value |
| Coca-Cola | Brian J. Smith | Senior Executive | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 126,972 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Charter (Class A) | Christopher Winfrey | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 124,922 | 124,922 | - | - | Stock Options | |
| Acumen Pharma Inc | Derek M. Meisner | Chief Legal Office & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 120,800 | 120,800 | - | - | Employee Stock Option (right to buy) | |
| ChargePoint Holdings Inc (Class A) | Eric Sidle | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.76 per share. | 17 Jan 2023 | 120,424 | 950,726 | - | 0.8 | 91,522 | Common Stock |
| ChargePoint Holdings Inc (Class A) | Eric Sidle | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 120,424 | 118,555 | - | - | Stock Option (right to buy) | |
| Acumen Pharma Inc | Eric Siemers | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 120,200 | 120,200 | - | - | Employee Stock Option (right to buy) | |
| Acumen Pharma Inc | Russell Barton | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 120,200 | 120,200 | - | - | Employee Stock Option (right to buy) | |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 120,000 | 120,000 | - | - | Stock Option (Right to Buy) | |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 184.47 per share. | 17 Jan 2023 | 117,753 | 2,326,233 (3%) | 0% | 184.5 | 21,721,896 | Common Stock |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 117,753 | 1,259,228 | - | - | Employee Stock Option | |
| Day One Biopharma Inc | Charles N. York | COO, CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 116,000 | 116,000 | - | - | Stock Option (right to buy Common Stock) | |
| Inspirato Incorporated (Class A) | David S. Kallery | PRESIDENT | 17 Jan 2023 | 115,639 | 115,639 | - | 3.8 | 439,428 | CLASS A COMMON STOCK | |
| Acumen Pharma Inc | Daniel O'Connell | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 114,000 | 116,685 | - | 0 | Common Stock | |
| Schneider National Inc (Class B) | Paul J. Schneider | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Jan 2023 | 111,354 | 526,599 (0%) | 0% | 0 | Class B Common Stock | |
| Charter (Class A) | Thomas M. Rutledge | Director, Executive Chairman | 17 Jan 2023 | 110,225 | 110,225 | - | - | Stock Options | ||
| Cue Biopharma Inc | Matteo Levisetti | Chief Medical Officer | 17 Jan 2023 | 110,000 | 110,000 | - | - | Stock Option (right to buy) | ||
| Ventyx Biosciences Inc | Christopher W. Krueger | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 108,750 | 108,750 | - | - | Stock Option (Right to Buy) | |
| Ventyx Biosciences Inc | Martin Auster | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 108,750 | 108,750 | - | - | Stock Option (Right to Buy) | |
| Ventyx Biosciences Inc | John M. Nuss | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 108,750 | 108,750 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 104,600 | 104,600 | - | - | Stock Option (Right to Buy) | |
| Cellectar Biosciences Inc | Chad J. Kolean | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 104,000 | 104,000 | - | - | Stock option (right to buy) | |
| Outlook Therapeutics Inc | Jeff Evanson | Chief Commercial Officer | 17 Jan 2023 | 103,255 | 1,012,975 (1%) | 0% | 1.2 | 125,971 | Common Stock | |
| Prologis | Hamid R. Moghadam | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 101,918 | 1,485,906 | - | - | LTIP Units | |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 101,115 | 151,346 | - | 0 | Common Stock | |
| ADT Inc | Daniel M. Bresingham | EVP, Commercial | Sale of securities on an exchange or to another person at price $ 9.60 per share. | 17 Jan 2023 | 100,000 | 1,934,073 (0%) | 0% | 9.6 | 960,000 | Common Stock |
| ADT Inc | Daniel M. Bresingham | EVP, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.27 per share. | 17 Jan 2023 | 100,000 | 2,034,073 (0%) | 0% | 5.3 | 527,000 | Common Stock |
| ADT Inc | Daniel M. Bresingham | EVP, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 100,000 | 1,161,070 | - | - | Stock Options | |
| Ginkgo Bioworks Holdings Inc (Class A) | Jason Kelly | Director, See remarks | Sale of securities on an exchange or to another person at price $ 1.92 per share. | 17 Jan 2023 | 100,000 | 16,072,783 | - | 1.9 | 192,100 | Class A Common Stock |
| Nine Energy Service Inc | Warren Lynn Frazier | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 14.99 per share. | 17 Jan 2023 | 100,000 | 3,349,087 (10%) | 0% | 15.0 | 1,499,220 | Common Stock |
| Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.28 per share. | 17 Jan 2023 | 100,000 | 2,227,950 (4%) | 0% | 1.3 | 128,000 | Common Stock |
| Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 100,000 | 326,543 | - | - | Option (Right to Buy) | |
| Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.51 per share. | 17 Jan 2023 | 100,000 | 2,327,950 (4%) | 0% | 0.5 | 51,000 | Common Stock |
| Johnson & Johnson | Joaquin Duato | Director, CEO and Chairman of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 173.43 per share. | 17 Jan 2023 | 98,795 | 295,720 (0%) | 0% | 173.4 | 17,134,017 | Common Stock |
| Relay Therapeutics Inc | Brian Adams | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 97,630 | 97,630 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 97,630 | 97,630 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Peter Rahmer | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 97,630 | 97,630 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Peter Rahmer | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 97,630 | 97,630 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Peter Rahmer | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 97,630 | 159,280 | - | 0 | Common Stock | |
| DocuSign Inc | Daniel D. Springer | Director | 17 Jan 2023 | 96,077 | 1,428,258 (0%) | 0% | 57.3 | 5,504,251 | Common Stock | |
| Wendy`s Co (Class A) | Leigh A. Burnside | SVP, CAO & CFO US | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.10 per share. | 17 Jan 2023 | 92,437 | 78,081 (0%) | 0% | 23.1 | 2,135,295 | Common Stock |
| Inspirato Incorporated (Class A) | David S. Kallery | PRESIDENT | 17 Jan 2023 | 91,905 | 194,152 | - | 3.8 | 349,239 | CLASS A COMMON STOCK | |
| Relay Therapeutics Inc | Brian Adams | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 85,425 | 136,956 | - | 0 | Common Stock | |
| Iovance Biotherapeutics Inc | Frederick G. Vogt | Interim CEO & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 83,325 | 166,675 | - | - | Restricted Stock Units | |
| Iovance Biotherapeutics Inc | Frederick G. Vogt | Interim CEO & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 83,325 | 85,325 (0%) | 0% | 0 | Common Stock | |
| Super Micro Computer | Charles Liang | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 83,044 | 148,216 | - | - | Employee Stock Option (right to buy) | |
| Super Micro Computer | Charles Liang | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.70 per share. | 17 Jan 2023 | 83,044 | 6,718,273 (13%) | 0% | 20.7 | 1,719,011 | Common Stock |
| Super Micro Computer | Chiu-Chu Liu Liang | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.70 per share. | 17 Jan 2023 | 83,044 | 6,718,273 (13%) | 0% | 20.7 | 1,719,011 | Common Stock |
| Super Micro Computer | Chiu-Chu Liu Liang | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 83,044 | 148,216 | - | - | Employee Stock Option (right to buy) | |
| Ribbon Communications Inc | Sam Bucci | EVP & Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 81,967 | 81,967 | - | - | Restricted Stock Units (RSU) | |
| Charter (Class A) | Thomas M. Rutledge | Director, Executive Chairman | 17 Jan 2023 | 81,945 | 0 (0%) | 0% | 0 | Class A Common Stock | ||
| Charter (Class A) | Thomas M. Rutledge | Director, Executive Chairman | 17 Jan 2023 | 81,945 | 165,145 (0%) | 0% | 0 | Class A Common Stock | ||
| Inspirato Incorporated (Class A) | David S. Kallery | PRESIDENT | 17 Jan 2023 | 81,555 | 81,555 | - | 3.8 | 309,909 | CLASS A COMMON STOCK | |
| Super Micro Computer | Charles Liang | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 80,150 | 68,066 | - | - | Employee Stock Option (right to buy) | |
| Super Micro Computer | Charles Liang | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.70 per share. | 17 Jan 2023 | 80,150 | 6,748,423 (13%) | 0% | 20.7 | 1,659,105 | Common Stock |
| Super Micro Computer | Chiu-Chu Liu Liang | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 80,150 | 68,066 | - | - | Employee Stock Option (right to buy) | |
| Super Micro Computer | Chiu-Chu Liu Liang | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.70 per share. | 17 Jan 2023 | 80,150 | 6,748,423 (13%) | 0% | 20.7 | 1,659,105 | Common Stock |
| Schneider National Inc (Class B) | Paul J. Schneider | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Jan 2023 | 76,000 | 637,953 (0%) | 0% | 0 | Class B Common Stock | |
| Schneider National Inc (Class B) | Paul J. Schneider | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Jan 2023 | 76,000 | 1,290,320 (1%) | 0% | 0 | Class B Common Stock | |
| Day One Biopharma Inc | Jeremy Bender | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 76,000 | 76,000 | - | - | Restricted Stock Units | |
| Relay Therapeutics Inc | Brian Adams | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 73,220 | 73,220 | - | - | Stock Option (Right to Buy) | |
| DocuSign Inc | Daniel D. Springer | Director | 17 Jan 2023 | 72,326 | 1,599,018 (0%) | 0% | 57.6 | 4,163,808 | Common Stock | |
| Day One Biopharma Inc | Samuel Blackman | Chief Medical Officer | 17 Jan 2023 | 72,000 | 72,000 | - | - | Stock Option (right to buy Common Stock) | ||
| Keurig Dr Pepper | Robert J. Gamgort | Director, CEO & Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 71,614 | 3,374,800 (0%) | 0% | 0 | Common Stock | |
| Hyperion DeFi Inc | John P. Gandolfo | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 68,235 | 68,235 | - | - | Stock Option (right to buy) | |
| Eastside Distilling Inc | Elizabeth Ann Levy-Navarro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 67,905 | 156,561 (1%) | 0% | 0 | Common Stock | |
| Xos Inc | Giordano Sordoni | Director, Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 1.01 per share. | 17 Jan 2023 | 66,905 | 23,798,534 | - | 1.0 | 67,574 | Common Stock |
| Inspirato Incorporated (Class A) | David S. Kallery | PRESIDENT | 17 Jan 2023 | 66,666 | 102,247 | - | 3.9 | 262,664 | CLASS A COMMON STOCK | |
| iSpecimen Inc | Jill Mullan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 66,637 | 10,000 | - | - | Option | |
| iSpecimen Inc | Jill Mullan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.00 per share. | 17 Jan 2023 | 66,637 | 246,226 | - | 1 | 66,637 | Common Stock |
| Charter (Class A) | Richard J. DiGeronimo | President-Product & Technology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 66,135 | 66,135 | - | - | Stock Options | |
| Prologis | Edward S. Nekritz | Chief Legal Off./Gen. Counsel | 17 Jan 2023 | 64,283 | 1,116,587 | - | - | LTIP Units | ||
| Prologis | Eugene Frederick Reilly | Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 64,283 | 708,017 | - | - | LTIP Units | |
| Prologis | Gary E. Anderson | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 64,283 | 649,401 | - | - | LTIP Units | |
| Designer Brands Inc (Class A) | William L. Jordan | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 62,630 | 62,630 | - | - | Restricted Stock Unit | |
| Designer Brands Inc (Class A) | Jared A. Poff | EVP & CFO | 17 Jan 2023 | 62,630 | 62,630 | - | - | Restricted Stock Unit | ||
| Designer Brands Inc (Class A) | James S. Weinberg | EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 62,630 | 62,630 | - | - | Restricted Stock Unit | |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 182.27 per share. | 17 Jan 2023 | 60,229 | 2,314,963 (3%) | 0% | 182.3 | 10,977,940 | Common Stock |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 60,229 | 1,198,999 | - | - | Employee Stock Option | |
| Alphatec Holdings Inc | Patrick S Miles | Director, CEO | Sale of securities on an exchange or to another person at price $ 13.30 per share. | 17 Jan 2023 | 60,000 | 5,541,633 (9%) | 0% | 13.3 | 798,000 | Common Stock |
| Alphatec Holdings Inc | Patrick S Miles | Director, CEO | Sale of securities on an exchange or to another person at price $ 13.05 per share. | 17 Jan 2023 | 60,000 | 5,601,633 (9%) | 0% | 13.1 | 783,000 | Common Stock |
| Alphatec Holdings Inc | Patrick S Miles | Director, CEO | Sale of securities on an exchange or to another person at price $ 13.33 per share. | 17 Jan 2023 | 60,000 | 5,481,633 (8%) | 0% | 13.3 | 799,800 | Common Stock |
| AMMO Inc | Fred W. Wagenhals | Director, CEO, Ten Percent Owner | 17 Jan 2023 | 60,000 | 7,344,200 | - | 3.5 | 210,000 | Common Stock | |
| Baxter International | Jeanne K. Mason | SVP, Human Resources | Sale of securities on an exchange or to another person at price $ 44.70 per share. | 17 Jan 2023 | 59,477 | 126,231 (0%) | 0% | 44.7 | 2,658,622 | Common Stock, $1 par value |
| Baxter International | Jeanne K. Mason | SVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.82 per share. | 17 Jan 2023 | 59,477 | 185,708 (0%) | 0% | 37.8 | 2,249,420 | Common Stock, $1 par value |
| Greif Inc (Class A) | Peter G. Watson | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 17 Jan 2023 | 57,772 | 326,711 (1%) | 0% | 0 | Class A Common Stock | |
| Credo Tech Grp Holding Ltd | Yat Tung Lam | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 17 Jan 2023 | 57,379 | 4,620,000 | - | 15.0 | 860,725 | Ordinary Shares |
| Ionis Pharma Inc | Brett P. Monia | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 57,267 | 145,929 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Brett P. Monia | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 57,267 | 176,861 | - | - | Restricted Stock Unit | |
| Insight Molecular Diagnostics Inc | James Yang Liu | Controller, PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 57,065 | 57,065 | - | - | Option to Purchase Common Stock | |
| Xos Inc | Giordano Sordoni | Director, Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 1.06 per share. | 17 Jan 2023 | 56,729 | 23,731,629 | - | 1.1 | 60,133 | Common Stock |
| Eastside Distilling Inc | Eric Finnsson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 55,743 | 142,575 (1%) | 0% | 0 | Common Stock | |
| Eastside Distilling Inc | Robert Grammen | Director | 17 Jan 2023 | 55,743 | 279,478 (2%) | 0% | 0 | Common Stock | ||
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 185.35 per share. | 17 Jan 2023 | 54,057 | 2,272,176 (3%) | 0% | 185.4 | 10,019,514 | Common Stock |
| JPMC | Mary Callahan Erdoes | CEO Asset & Wealth Management | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 52,892 | 52,892 | - | - | Restricted Stock Units | |
| Yum China Holdings Inc | Joey Wat | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 52,166 | 274,252 (0%) | 0% | 0 | Common Stock | |
| Nine Energy Service Inc | Warren Lynn Frazier | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.13 per share. | 17 Jan 2023 | 52,066 | 2,851,249 (9%) | 0% | 4.1 | 215,236 | Common Stock |
| Charter (Class A) | Christopher Winfrey | President and CEO | Other type of transaction at price $ 0.00 per share. | 17 Jan 2023 | 50,536 | 0 | - | - | Stock Options | |
| Charter (Class A) | Christopher Winfrey | President and CEO | Other type of transaction at price $ 0.00 per share. | 17 Jan 2023 | 50,536 | 299,681 | - | - | Stock Options | |
| Applied Digital Corp | Wesley Cummins | Director, CEO; Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.25 per share. | 17 Jan 2023 | 50,000 | 1,600,686 | - | 2.3 | 112,500 | Common Stock |
| Credo Tech Grp Holding Ltd | Yat Tung Lam | Director, Chief Operating Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Jan 2023 | 50,000 | 3,138,888 | - | 0 | Ordinary Shares | |
| Tenaya Therapeutics Inc | David V. Goeddel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.49 per share. | 17 Jan 2023 | 49,463 | 9,664,847 | - | 2.5 | 123,395 | Common Stock |
| Ribbon Communications Inc | Miguel A. Lopez | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 49,180 | 49,180 | - | - | Restricted Stock Units (RSU) | |
| Samsara Inc (Class A) | John Bicket | Director, See remarks, Ten Percent Owner | 17 Jan 2023 | 48,976 | 87,149,588 | - | - | Class B Common Stock | ||
| Samsara Inc (Class A) | Sanjit Biswas | Director, Chief Executive Officer, Ten Percent Owner | 17 Jan 2023 | 48,923 | 87,012,600 | - | - | Class B Common Stock | ||
| DocuSign Inc | Daniel D. Springer | Director | 17 Jan 2023 | 48,128 | 1,528,971 (0%) | 0% | 59.6 | 2,869,391 | Common Stock | |
| Ventyx Biosciences Inc | Raju S. Mohan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 47,375 | 47,375 | - | - | Restricted Stock Units | |
| Greif Inc (Class A) | Lawrence A. Hilsheimer | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 47,088 | 132,093 (0%) | 0% | 0 | Class A Common Stock | |
| Prologis | Michael Curless | Chief Customer Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 46,542 | 793,080 | - | - | LTIP Units | |
| Xos Inc | Giordano Sordoni | Director, Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 0.99 per share. | 17 Jan 2023 | 44,634 | 23,843,168 | - | 1.0 | 44,188 | Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, Chief Executive Officer, Ten Percent Owner | 17 Jan 2023 | 44,588 | 86,968,012 | - | - | Class B Common Stock | ||
| Samsara Inc (Class A) | Sanjit Biswas | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.66 per share. | 17 Jan 2023 | 44,588 | 91,438 | - | 12.7 | 564,640 | Class A Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, Chief Executive Officer, Ten Percent Owner | 17 Jan 2023 | 44,588 | 136,026 | - | 0 | Class A Common Stock | ||
| Samsara Inc (Class A) | John Bicket | Director, See remarks, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.66 per share. | 17 Jan 2023 | 44,501 | 27,807 | - | 12.7 | 563,512 | Class A Common Stock |
| Samsara Inc (Class A) | John Bicket | Director, See remarks, Ten Percent Owner | 17 Jan 2023 | 44,501 | 72,308 | - | 0 | Class A Common Stock | ||
| Samsara Inc (Class A) | John Bicket | Director, See remarks, Ten Percent Owner | 17 Jan 2023 | 44,501 | 87,105,087 | - | - | Class B Common Stock | ||
| Herc Holdings Inc | Carl C. Icahn | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 144.64 per share. | 17 Jan 2023 | 44,213 | 3,623,866 (12%) | 0% | 144.6 | 6,394,968 | Shares |
| Credo Tech Grp Holding Ltd | Yat Tung Lam | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 17 Jan 2023 | 42,621 | 4,677,379 | - | 15.0 | 639,409 | Ordinary Shares |
| Cadence Design | Lip-Bu Tan | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.79 per share. | 17 Jan 2023 | 42,500 | 645,089 (0%) | 0% | 30.8 | 1,308,575 | Common Stock |
| Cadence Design | Lip-Bu Tan | Director, Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 42,500 | 382,500 | - | - | Non- Qualified Stock Option (right to buy) | |
| AMMO Inc | Robert J. Goodmanson | Director, President | Grant, award, or other acquisition of securities at price $ 3.50 per share. | 17 Jan 2023 | 42,500 | 277,116 | - | 3.5 | 148,750 | Common Stock |
| FirstCash Holdings Inc | Douglas R. Rippel | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 88.20 per share. | 17 Jan 2023 | 42,127 | 7,381,020 (17%) | 0% | 88.2 | 3,715,601 | Common Stock |
| Credo Tech Grp Holding Ltd | Yat Tung Lam | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 17 Jan 2023 | 42,021 | 3,527,979 | - | 15.0 | 630,416 | Ordinary Shares |
| Supernus Pharma Inc | Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.56 per share. | 17 Jan 2023 | 41,920 | 816,619 (1%) | 0% | 9.6 | 400,755 | Common Stock |
| Supernus Pharma Inc | Jack A. Khattar | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 41,920 | 58,080 | - | - | Employee Stock Option (Right to Buy) | |
| Skyline Champion Corp | Mark Yost | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 55.47 per share. | 17 Jan 2023 | 41,223 | 113,970 (0%) | 0% | 55.5 | 2,286,640 | Common Stock |
| Ribbon Communications Inc | Patrick W. Macken | EVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 40,983 | 40,983 | - | - | Restricted Stock Units (RSU) | |
| Rekor Systems Inc | David Desharnais | President and COO | 17 Jan 2023 | 40,484 | 334,516 (1%) | 0% | 1.9 | 77,324 | Common Stock | |
| Flywire Corp | Rob Orgel | President and COO | Sale of securities on an exchange or to another person at price $ 25.78 per share. | 17 Jan 2023 | 40,000 | 157,051 | - | 25.8 | 1,031,144 | Voting Common Stock |
| Flywire Corp | Rob Orgel | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 40,000 | 360,000 | - | - | Stock Option (right to buy) | |
| Flywire Corp | Rob Orgel | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.95 per share. | 17 Jan 2023 | 40,000 | 197,051 | - | 4.0 | 158,000 | Voting Common Stock |
| Herc Holdings Inc | Carl C. Icahn | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 141.29 per share. | 17 Jan 2023 | 39,578 | 3,584,288 (12%) | 0% | 141.3 | 5,591,976 | Shares |
| Ginkgo Bioworks Holdings Inc (Class A) | Reshma P. Shetty | Director, See remarks, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.92 per share. | 17 Jan 2023 | 37,650 | 16,459,855 | - | 1.9 | 72,363 | Class A Common Stock |
| Wendy`s Co (Class A) | Leigh A. Burnside | SVP, CAO & CFO US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 36,724 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Wendy`s Co (Class A) | Leigh A. Burnside | SVP, CAO & CFO US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.71 per share. | 17 Jan 2023 | 36,724 | 170,518 (0%) | 0% | 19.7 | 723,830 | Common Stock |
| Iovance Biotherapeutics Inc | Frederick G. Vogt | Interim CEO & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.43 per share. | 17 Jan 2023 | 36,441 | 48,884 (0%) | 0% | 6.4 | 234,316 | Common Stock |
| Charter (Class A) | David G. Ellen | Senior Executive VicePresident | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 36,374 | 36,374 | - | - | Stock Options | |
| Charter (Class A) | Jessica M. Fischer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 36,374 | 36,374 | - | - | Stock Options | |
| Day One Biopharma Inc | Charles N. York | COO, CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 36,000 | 36,000 | - | - | Restricted Stock Units | |
| JPMC | Marianne Lake | Co-CEO CCB | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 35,796 | 35,796 | - | - | Restricted Stock Units | |
| JPMC | Jennifer A Piepszak | Co-CEO CCB | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 35,796 | 35,796 | - | - | Restricted Stock Units | |
| Schneider National Inc (Class B) | Kathleen M. Zimmermann | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Jan 2023 | 35,354 | 442,372 (0%) | 0% | 0 | Class B Common Stock | |
| Schneider National Inc (Class B) | Paul J. Schneider | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Jan 2023 | 35,354 | 561,953 (0%) | 0% | 0 | Class B Common Stock | |
| Schneider National Inc (Class B) | Therese A. Koller | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Jan 2023 | 35,345 | 1,659,913 (1%) | 0% | 0 | Class B Common Stock | |
| Schneider National Inc (Class B) | Therese A. Koller | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Jan 2023 | 35,345 | 1,694,858 (1%) | 0% | 0 | Class B Common Stock | |
| Microbot Medical Inc | Eyal Morag | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Microbot Medical Inc | Simon Sharon | General Manager, CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 34,000 | 102,117 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.61 per share. | 17 Jan 2023 | 34,000 | 96,961 (0%) | 0% | 5.6 | 190,740 | Common Stock |
| Outlook Therapeutics Inc | Jeff Evanson | Chief Commercial Officer | 17 Jan 2023 | 33,738 | 1,116,230 (2%) | 0% | 1.3 | 42,173 | Common Stock | |
| Samsara Inc (Class A) | John Bicket | Director, See remarks, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.24 per share. | 17 Jan 2023 | 33,166 | 27,807 | - | 12.2 | 406,031 | Class A Common Stock |
| Samsara Inc (Class A) | John Bicket | Director, See remarks, Ten Percent Owner | 17 Jan 2023 | 33,166 | 60,973 | - | 0 | Class A Common Stock | ||
| Samsara Inc (Class A) | Sanjit Biswas | Director, Chief Executive Officer, Ten Percent Owner | 17 Jan 2023 | 33,052 | 124,490 | - | 0 | Class A Common Stock | ||
| Samsara Inc (Class A) | Sanjit Biswas | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.24 per share. | 17 Jan 2023 | 33,052 | 91,438 | - | 12.2 | 404,573 | Class A Common Stock |
| Inspirato Incorporated (Class A) | David S. Kallery | PRESIDENT | 17 Jan 2023 | 32,830 | 35,581 | - | 29.6 | 971,768 | CLASS A COMMON STOCK | |
| Greif Inc (Class A) | Gary R. Martz | Executive VP & General Counsel | 17 Jan 2023 | 32,175 | 106,322 (0%) | 0% | 0 | Class A Common Stock | ||
| Prologis | Eugene Frederick Reilly | Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 32,119 | 633,227 | - | - | LTIP Units | |
| JPMC | Douglas B. Petno | CEO Commercial Banking | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 31,522 | 31,522 | - | - | Restricted Stock Units | |
| Scotts Miracle-Gro Co (Class A) | James Hagedorn | Director, Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 61.09 per share. | 17 Jan 2023 | 31,077 | 212,401 (0%) | 0% | 61.1 | 1,898,466 | Common Shares |
| Coterra Energy | Dan O. Dinges | Director, Executive Chairman of Board | 17 Jan 2023 | 30,682 | 3,965,188 (0%) | 0% | 25.3 | 777,482 | Common Stock | |
| JPMC | Stacey Friedman | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 30,453 | 30,453 | - | - | Restricted Stock Units | |
| DocuSign Inc | Daniel D. Springer | Director | 17 Jan 2023 | 30,280 | 1,377,826 (0%) | 0% | 60.4 | 1,828,004 | Common Stock | |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 30,145 | 742,585 (0%) | 0% | 0 | Class A Common Stock | |
| Frequency Electronics Inc | Thomas Mcclelland | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 30,000 | 42,670 (0%) | 0% | 0 | Common Stock | |
| AMKOR Tech Inc | Guillaume Marie Jean Rutten | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 30.73 per share. | 17 Jan 2023 | 30,000 | 155,000 (0%) | 0% | 30.7 | 921,900 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director | Sale of securities on an exchange or to another person at price $ 26.30 per share. | 17 Jan 2023 | 29,506 | 67,455 (0%) | 0% | 26.3 | 776,111 | Common Stock |
| JPMC | Ashley Bacon | Chief Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 29,385 | 29,385 | - | - | Restricted Stock Units | |
| Prologis | Gary E. Anderson | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 28,413 | 576,337 | - | - | LTIP Units | |
| Herc Holdings Inc | Carl C. Icahn | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 144.23 per share. | 17 Jan 2023 | 28,366 | 3,668,079 (12%) | 0% | 144.2 | 4,091,228 | Common Stock, par value $0.01 per share ("Shares") |
| Keurig Dr Pepper | Robert J. Gamgort | Director, CEO & Executive Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 17 Jan 2023 | 28,323 | 3,346,477 (0%) | 0% | 0 | Common Stock | |
| Greif Inc (Class A) | Peter G. Watson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 28,313 | 36,531 | - | - | Restricted Stock Unit | |
| Greif Inc (Class A) | Peter G. Watson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 28,313 | 256,963 (0%) | 0% | 0 | Class A Common Stock | |
| Wendy`s Co (Class A) | Leigh A. Burnside | SVP, CAO & CFO US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 28,005 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Wendy`s Co (Class A) | Leigh A. Burnside | SVP, CAO & CFO US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.36 per share. | 17 Jan 2023 | 28,005 | 109,550 (0%) | 0% | 15.4 | 430,017 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 28,000 | 610,779 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 28,000 | 638,779 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 28,000 | 666,779 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 20.02 per share. | 17 Jan 2023 | 28,000 | 254,554 | - | 20.0 | 560,560 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 17 Jan 2023 | 28,000 | 282,554 | - | 5.0 | 141,120 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 20.87 per share. | 17 Jan 2023 | 28,000 | 254,554 | - | 20.9 | 584,360 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 17 Jan 2023 | 28,000 | 282,554 | - | 5.0 | 141,120 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 20.23 per share. | 17 Jan 2023 | 28,000 | 254,554 | - | 20.2 | 566,440 | Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 17 Jan 2023 | 28,000 | 282,554 | - | 5.0 | 141,120 | Common Stock |
| Build A Bear Workshop Inc | Sharon Price John | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.43 per share. | 17 Jan 2023 | 27,225 | 545,657 (3%) | 0% | 9.4 | 256,732 | Common Stock |
| Build A Bear Workshop Inc | Sharon Price John | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 27,225 | 0 | - | - | Employee Stock Option (right to buy) | |
| Outlook Therapeutics Inc | Jeff Evanson | Chief Commercial Officer | 17 Jan 2023 | 27,162 | 1,149,968 (2%) | 0% | 1.3 | 35,582 | Common Stock | |
| Acumen Pharma Inc | Derek M. Meisner | Chief Legal Office & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 26,800 | 26,800 | - | 0 | Common Stock | |
| Acumen Pharma Inc | Eric Siemers | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 26,700 | 26,700 | - | 0 | Common Stock | |
| Acumen Pharma Inc | Russell Barton | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 26,700 | 26,700 | - | 0 | Common Stock | |
| Wendy`s Co (Class A) | Leigh A. Burnside | SVP, CAO & CFO US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 26,528 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Wendy`s Co (Class A) | Leigh A. Burnside | SVP, CAO & CFO US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.09 per share. | 17 Jan 2023 | 26,528 | 81,545 (0%) | 0% | 10.1 | 267,601 | Common Stock |
| Trimble | Steven W. Berglund | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.14 per share. | 17 Jan 2023 | 26,211 | 245,505 (0%) | 0% | 54.1 | 1,419,064 | Common Stock |
| Trimble | Steven W. Berglund | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 26,211 | 30,589 | - | - | Restricted Stock Units | |
| Riot Platforms Inc | Lance D'Ambrosio | Director | Sale of securities on an exchange or to another person at price $ 6.39 per share. | 17 Jan 2023 | 26,000 | 69,441 (0%) | 0% | 6.4 | 166,101 | Common Stock |
| Prologis | Edward S. Nekritz | Chief Legal Off./Gen. Counsel | 17 Jan 2023 | 25,943 | 1,043,849 | - | - | LTIP Units | ||
| Cadence Design | Lip-Bu Tan | Director, Executive Chair | Sale of securities on an exchange or to another person at price $ 173.70 per share. | 17 Jan 2023 | 25,939 | 606,260 (0%) | 0% | 173.7 | 4,505,550 | Common Stock |
| Build A Bear Workshop Inc | Sharon Price John | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 23.51 per share. | 17 Jan 2023 | 25,910 | 519,747 (3%) | 0% | 23.5 | 609,268 | Common Stock |
| Agilon Health Inc | Benjamin Shaker | Chief Markets Officer | Sale of securities on an exchange or to another person at price $ 19.91 per share. | 17 Jan 2023 | 25,722 | 25,625 | - | 19.9 | 512,225 | Common Stock |
| Agilon Health Inc | Benjamin Shaker | Chief Markets Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 25,722 | 51,129 | - | - | Options (Right to buy) | |
| Agilon Health Inc | Benjamin Shaker | Chief Markets Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.00 per share. | 17 Jan 2023 | 25,722 | 51,347 | - | 3 | 77,166 | Common Stock |
| Supernus Pharma Inc | Jack A. Khattar | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 40.03 per share. | 17 Jan 2023 | 25,446 | 791,173 (1%) | 0% | 40.0 | 1,018,728 | Common Stock |
| Opendoor Tech Inc | Christina Schwartz | See Remarks | Sale of securities on an exchange or to another person at price $ 1.67 per share. | 17 Jan 2023 | 25,264 | 803,350 | - | 1.7 | 42,249 | Common Stock |
| Ionis Pharma Inc | Brett P. Monia | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 39.49 per share. | 17 Jan 2023 | 25,066 | 120,863 (0%) | 0% | 39.5 | 989,947 | Common Stock |
| Allegro Microsystems Inc | Max R. Glover | SVP of Worldwide Sales | 17 Jan 2023 | 25,000 | 234,689 | - | 34.2 | 855,340 | Common Stock | |
| AMMO Inc | Robert D. Wiley | CFO | Grant, award, or other acquisition of securities at price $ 3.50 per share. | 17 Jan 2023 | 25,000 | 291,665 | - | 3.5 | 87,500 | Common Stock |
| Greif Inc (Class A) | Ole G. Rosgaard | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 24,517 | 68,244 (0%) | 0% | 0 | Class A Common Stock | |
| Easterly Government Properties Inc | William C. Trimble | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 24,512 | 24,512 | - | - | LTIP Units | |
| Wendy`s Co (Class A) | Leigh A. Burnside | SVP, CAO & CFO US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.52 per share. | 17 Jan 2023 | 24,244 | 133,794 (0%) | 0% | 18.5 | 448,878 | Common Stock |
| Wendy`s Co (Class A) | Leigh A. Burnside | SVP, CAO & CFO US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 24,244 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Trimble | Robert G. Painter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.14 per share. | 17 Jan 2023 | 24,090 | 160,878 (0%) | 0% | 54.1 | 1,304,233 | Common Stock |
| Trimble | Robert G. Painter | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 24,090 | 135,874 | - | - | Restricted Stock Units | |
| JPMC | Jeremy Barnum | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 24,042 | 24,042 | - | - | Restricted Stock Units | |
| Ionis Pharma Inc | Elizabeth L. Hougen | EVP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 23,154 | 52,143 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Elizabeth L. Hougen | EVP, Finance & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 23,154 | 81,715 (0%) | 0% | 0 | Common Stock | |
| Yum China Holdings Inc | Joey Wat | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.09 per share. | 17 Jan 2023 | 23,001 | 251,251 (0%) | 0% | 57.1 | 1,313,127 | Common Stock |
| Day One Biopharma Inc | Samuel Blackman | Chief Medical Officer | 17 Jan 2023 | 23,000 | 23,000 | - | - | Restricted Stock Units | ||
| Designer Brands Inc (Class A) | Mark Haley | SVP, Controller and PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 22,965 | 22,965 | - | - | Restricted Stock Unit | |
| Eastside Distilling Inc | Stephanie Kilkenny | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 22,804 | 22,804 (0%) | 0% | 0 | Common Stock | |
| Eastside Distilling Inc | Joseph Giansante | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 22,804 | 49,783 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Richard S. Geary | EVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 21,983 | 78,356 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Richard S. Geary | EVP, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 21,983 | 46,077 | - | - | Restricted Stock Unit | |
| DocuSign Inc | Daniel D. Springer | Director | 17 Jan 2023 | 21,919 | 1,577,099 (0%) | 0% | 58.7 | 1,285,769 | Common Stock | |
| Ionis Pharma Inc | Patrick R. O'Neil | EVP CLO & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 21,871 | 47,655 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Patrick R. O'Neil | EVP CLO & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 21,871 | 56,515 (0%) | 0% | 0 | Common Stock | |
| Prologis | Daniel Letter | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 21,825 | 161,932 | - | - | LTIP Units | |
| Republic Bancorp Inc KY | Logan M. Pichel | Director, PRESIDENT & CEO, REPUBLIC BANK | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 21,505 | 21,505 | - | - | Employee Stock Option (right to buy) | |
| Agilon Health Inc | Benjamin Shaker | Chief Markets Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 20,723 | 30,406 | - | - | Options (Right to buy) | |
| Agilon Health Inc | Benjamin Shaker | Chief Markets Officer | Sale of securities on an exchange or to another person at price $ 19.78 per share. | 17 Jan 2023 | 20,723 | 25,625 | - | 19.8 | 409,889 | Common Stock |
| Agilon Health Inc | Benjamin Shaker | Chief Markets Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.00 per share. | 17 Jan 2023 | 20,723 | 46,348 | - | 3 | 62,169 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 80.70 per share. | 17 Jan 2023 | 20,617 | 1,743,071 (10%) | 0% | 80.7 | 1,663,831 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 80.70 per share. | 17 Jan 2023 | 20,617 | 1,681,646 (9%) | 0% | 80.7 | 1,663,831 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 80.70 per share. | 17 Jan 2023 | 20,617 | 1,743,071 (10%) | 0% | 80.7 | 1,663,831 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 80.70 per share. | 17 Jan 2023 | 20,617 | 1,681,646 (9%) | 0% | 80.7 | 1,663,831 | Common Stock |
| Greif Inc (Class A) | Timothy L. Bergwall | SVP, President PPS & Soterra | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 20,282 | 52,840 (0%) | 0% | 0 | Class A Common Stock | |
| OppFi Inc (Class A) | Todd G. Schwartz | Director, Chief Executive Officer, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Jan 2023 | 20,000 | 94,967,285 | - | 0 | Class V Common Stock | |
| Agios Pharma Inc | David P. Schenkein | Director | 17 Jan 2023 | 20,000 | 116,363 | - | - | Stock option (right to buy) | ||
| Agios Pharma Inc | David P. Schenkein | Director | 17 Jan 2023 | 20,000 | 137,879 (0%) | 0% | 9.1 | 181,000 | Common stock | |
| Frequency Electronics Inc | Steven L. Bernstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 20,000 | 25,437 (0%) | 0% | 0 | Common Stock | |
| JFrog Ltd | Yoav Landman | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 23.05 per share. | 17 Jan 2023 | 20,000 | 7,366,342 | - | 23.1 | 461,052 | Ordinary Shares |
| Ventyx Biosciences Inc | William J. Sandborn | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 20,000 | 20,000 | - | - | Restricted Stock Units | |
| Cloudflare Inc (Class A) | Thomas Josef Seifert | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 20,000 | 24,058 | - | - | Employee Stock Option (right to buy) | |
| Cloudflare Inc (Class A) | Thomas Josef Seifert | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 20,000 | 28,925 | - | - | Class B Common Stock | |
| Cloudflare Inc (Class A) | Thomas Josef Seifert | Chief Financial Officer | 17 Jan 2023 | 20,000 | 8,925 | - | - | Class B Common Stock | ||
| Cloudflare Inc (Class A) | Thomas Josef Seifert | Chief Financial Officer | 17 Jan 2023 | 20,000 | 106,433 (0%) | 0% | - | Class A Common Stock | ||
| Baxter International | Jeanne K. Mason | SVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 19,826 | 19,826 | - | - | Stock Option (Right to Buy) | |
| Baxter International | Jeanne K. Mason | SVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 19,826 | 0 | - | - | Stock Option (Right to Buy) | |
| Baxter International | Jeanne K. Mason | SVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 19,825 | 39,652 | - | - | Stock Option (Right to Buy) | |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 19,417 | 21,414 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | C. Frank Bennett | EVP, Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 19,417 | 74,833 (0%) | 0% | 0 | Common Stock | |
| Rexford Industrial Realty Inc | Howard Schwimmer | Director, Co-CEO, Co-President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 19,367 | 510,171 | - | - | LTIP Units | |
| Rexford Industrial Realty Inc | Michael S. Frankel | Director, Co-CEO, Co-President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 19,367 | 449,106 | - | - | LTIP Units | |
| Agios Pharma Inc | David P. Schenkein | Director | 17 Jan 2023 | 18,966 | 118,913 (0%) | 0% | 28.8 | 546,600 | Common stock | |
| Scotts Miracle-Gro Co (Class A) | James Hagedorn | Director, Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 60.25 per share. | 17 Jan 2023 | 18,923 | 243,478 (0%) | 0% | 60.2 | 1,140,098 | Common Shares |
| Jabil | Steven D. Borges | EVP, CEO, DMS | Sale of securities on an exchange or to another person at price $ 78.52 per share. | 17 Jan 2023 | 18,525 | 175,645 (0%) | 0% | 78.5 | 1,454,583 | Common Stock |
| Samsara Inc (Class A) | John Bicket | Director, See remarks, Ten Percent Owner | 17 Jan 2023 | 18,447 | 87,086,640 | - | - | Class B Common Stock | ||
| Samsara Inc (Class A) | John Bicket | Director, See remarks, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.38 per share. | 17 Jan 2023 | 18,447 | 27,807 | - | 12.4 | 228,462 | Class A Common Stock |
| Samsara Inc (Class A) | John Bicket | Director, See remarks, Ten Percent Owner | 17 Jan 2023 | 18,447 | 46,254 | - | 0 | Class A Common Stock | ||
| Ventyx Biosciences Inc | Christopher W. Krueger | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 18,125 | 18,125 | - | - | Restricted Stock Units | |
| Ventyx Biosciences Inc | Martin Auster | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 18,125 | 18,125 | - | - | Restricted Stock Units | |
| Ventyx Biosciences Inc | John M. Nuss | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 18,125 | 18,125 | - | - | Restricted Stock Units | |
| Greif Inc (Class A) | Lawrence A. Hilsheimer | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 17 Jan 2023 | 18,109 | 113,984 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharma Inc (Class A) | Jason Rickard | SVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 18,087 | 366,823 (0%) | 0% | 0 | Class A Common Stock | |
| Cadence Design | Lip-Bu Tan | Director, Executive Chair | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Jan 2023 | 18,056 | 927,880 (0%) | 0% | 0 | Common Stock | |
| Schneider National Inc (Class B) | Mary P. Deprey | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Jan 2023 | 17,673 | 566,594 (0%) | 0% | 0 | Class B Common Stock | |
| JPMC | Lori A. Beer | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 17,631 | 17,631 | - | - | Restricted Stock Units | |
| Samsara Inc (Class A) | Sanjit Biswas | Director, Chief Executive Officer, Ten Percent Owner | 17 Jan 2023 | 17,336 | 86,950,676 | - | - | Class B Common Stock | ||
| Samsara Inc (Class A) | Sanjit Biswas | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.38 per share. | 17 Jan 2023 | 17,336 | 91,438 | - | 12.4 | 214,632 | Class A Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, Chief Executive Officer, Ten Percent Owner | 17 Jan 2023 | 17,336 | 108,774 | - | 0 | Class A Common Stock | ||
| Prologis | Daniel Letter | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 17,175 | 185,325 | - | - | LTIP Units | |
| Ensign Grp Inc | Suzanne D. Snapper | Director, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.89 per share. | 17 Jan 2023 | 16,991 | 227,745 (0%) | 0% | 10.9 | 185,032 | Common Stock |
| Ensign Grp Inc | Suzanne D. Snapper | Director, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 16,991 | 156,022 | - | - | Employee Stock Option (right to buy) | |
| Ensign Grp Inc | Suzanne D. Snapper | Director, CFO | Sale of securities on an exchange or to another person at price $ 96.00 per share. | 17 Jan 2023 | 16,991 | 210,754 (0%) | 0% | 96.0 | 1,631,075 | Common Stock |
| Prologis | Timothy D. Arndt | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 16,677 | 114,073 | - | - | LTIP Units | |
| Ribbon Communications Inc | Miguel A. Lopez | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 16,592 | 16,593 | - | - | Restricted Stock Units (RSU) | |
| Ribbon Communications Inc | Miguel A. Lopez | EVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 16,592 | 133,836 (0%) | 0% | 0 | Common Stock | |
| Charter (Class A) | Richard Dykhouse | EVP/Gen Counsel/Corp Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 16,534 | 16,534 | - | - | Stock Options | |
| Build A Bear Workshop Inc | Sharon Price John | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 22.65 per share. | 17 Jan 2023 | 16,096 | 502,336 (3%) | 0% | 22.7 | 364,637 | Common Stock |
| Neuronetics Inc | Stephen Furlong | CFO | Sale of securities on an exchange or to another person at price $ 6.13 per share. | 17 Jan 2023 | 16,050 | 373,269 (1%) | 0% | 6.1 | 98,387 | Common Stock |
| Piper Sandler Co`s | Jonathan J. Doyle | Director, Hd of Financial Services Group | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 17 Jan 2023 | 16,017 | 227,253 (1%) | 0% | 0 | Common Stock | |
| Samsara Inc (Class A) | Sanjit Biswas | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.59 per share. | 17 Jan 2023 | 15,871 | 91,438 | - | 12.6 | 199,768 | Class A Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, Chief Executive Officer, Ten Percent Owner | 17 Jan 2023 | 15,871 | 107,309 | - | 0 | Class A Common Stock | ||
| Samsara Inc (Class A) | John Bicket | Director, See remarks, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.59 per share. | 17 Jan 2023 | 15,810 | 27,807 | - | 12.6 | 199,024 | Class A Common Stock |
| Samsara Inc (Class A) | John Bicket | Director, See remarks, Ten Percent Owner | 17 Jan 2023 | 15,810 | 43,617 | - | 0 | Class A Common Stock | ||
| Ionis Pharma Inc | Eric E. Swayze | EVP Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 15,780 | 43,397 | - | - | Restricted Stock Unit | |
| Ionis Pharma Inc | Eric E. Swayze | EVP Research | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 15,780 | 35,672 (0%) | 0% | 0 | Common Stock | |
| ONE Grp Hospitality Inc | Emanuel N. Hilario | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.38 per share. | 17 Jan 2023 | 15,619 | 1,947,967 (6%) | 0% | 6.4 | 99,649 | Common Stock |
| Delta Air Lines | William Charles Carroll | SVP, Fin & Controller | Sale of securities on an exchange or to another person at price $ 38.20 per share. | 17 Jan 2023 | 15,529 | 16,780 (0%) | 0% | 38.2 | 593,208 | Common Stock |
| JPMC | Peter Scher | Vice Chairman | 17 Jan 2023 | 15,494 | 15,494 | - | - | Restricted Stock Units | ||
| JPMC | Robin Leopold | Head of Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 15,494 | 15,494 | - | - | Restricted Stock Units | |
| Sanmina Corp | Kurt Adzema | EVP & CFO | Sale of securities on an exchange or to another person at price $ 61.30 per share. | 17 Jan 2023 | 15,482 | 69,351 (0%) | 0% | 61.3 | 949,062 | Common Stock |
| Prologis | Hamid R. Moghadam | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 15,009 | 1,500,915 | - | - | LTIP Units | |
| Easterly Government Properties Inc | Darrell W. Crate | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 15,006 | 15,006 | - | - | LTIP Units | |
| Easterly Government Properties Inc | Michael P. Ibe | Director, EVP - Dev & Acquisitions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 15,006 | 15,006 | - | - | LTIP Units | |
| Ribbon Communications Inc | Eric Marmurek | SVP, Finance & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 15,000 | 15,000 | - | - | Restricted Stock Units (RSUs) | |
| Greif Inc (Class A) | Bala Sathyanarayanan | EVP, Chief Human Resources Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 14,859 | 28,365 (0%) | 0% | 0 | Class A Common Stock | |
| Greif Inc (Class A) | Lawrence A. Hilsheimer | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 14,850 | 36,120 | - | - | Restricted Stock Unit | |
| Greif Inc (Class A) | Lawrence A. Hilsheimer | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 14,850 | 91,369 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharma Inc (Class A) | Michael Shetzline | CMO,SVP,Head-Res&Drug | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 14,663 | 280,908 (0%) | 0% | 0 | Class A Common Stock | |
| Walmart | C. Douglas McMillon | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 145.30 per share. | 17 Jan 2023 | 14,650 | 1,442,218 (0%) | 0% | 145.3 | 2,128,594 | Common Stock |
| Super Micro Computer | Charles Liang | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 79.05 per share. | 17 Jan 2023 | 14,605 | 6,733,818 (13%) | 0% | 79.0 | 1,154,512 | Common Stock |
| Super Micro Computer | Chiu-Chu Liu Liang | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 79.05 per share. | 17 Jan 2023 | 14,605 | 6,733,818 (13%) | 0% | 79.0 | 1,154,512 | Common Stock |
| Kingstone Cos. Inc | Jennifer L. Gravelle | Chief Financial Officer | 17 Jan 2023 | 14,535 | 14,535 (0%) | 0% | 0 | Common Stock | ||
| Funko Inc (Class A) | Andrew Perlmutter | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 11.87 per share. | 17 Jan 2023 | 14,302 | 108,363 (0%) | 0% | 11.9 | 169,788 | Class A Common Stock |
| Olympic Steel Inc | Michael D. Siegal | Director, See Remarks, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Jan 2023 | 14,000 | 1,202,072 (10%) | 0% | 0 | Common Stock | |
| Super Micro Computer | Charles Liang | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 81.95 per share. | 17 Jan 2023 | 13,328 | 6,692,744 (13%) | 0% | 82.0 | 1,092,294 | Common Stock |
| Super Micro Computer | Chiu-Chu Liu Liang | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 81.95 per share. | 17 Jan 2023 | 13,328 | 6,692,744 (13%) | 0% | 82.0 | 1,092,294 | Common Stock |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 187.44 per share. | 17 Jan 2023 | 13,314 | 2,285,977 (3%) | 0% | 187.4 | 2,495,608 | Common Stock |
| Prologis | Michael Curless | Chief Customer Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 13,177 | 739,033 | - | - | LTIP Units | |
| Ionis Pharma Inc | Eugene Schneider | EVP, Chf Clinical Develop Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 13,046 | 27,078 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Eugene Schneider | EVP, Chf Clinical Develop Ofcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 13,046 | 40,070 | - | - | Restricted Stock Unit | |
| Destination XL Grp Inc | John F. Cooney | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 6.85 per share. | 17 Jan 2023 | 13,000 | 59,559 (0%) | 0% | 6.8 | 89,031 | Common Stock, $0.01 par value |
| SES AI Corp (Class A) | Jing Nealis | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 3.54 per share. | 17 Jan 2023 | 12,875 | 1,456,513 | - | 3.5 | 45,520 | Class A Common Stock |
| DocuSign Inc | Daniel D. Springer | Director | 17 Jan 2023 | 12,869 | 1,415,389 (0%) | 0% | 58.3 | 750,520 | Common Stock | |
| Yum China Holdings Inc | Johnson Huang | Chief Customer Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 12,520 | 54,883 (0%) | 0% | 0 | Common Stock | |
| Yum China Holdings Inc | Andy Yeung | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 12,520 | 27,561 (0%) | 0% | 0 | Common Stock | |
| Madrigal Pharma Inc | Richard S. Levy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 105.08 per share. | 17 Jan 2023 | 12,489 | 21,589 (0%) | 0% | 105.1 | 1,312,344 | Common Stock |
| Madrigal Pharma Inc | Richard S. Levy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 12,489 | 0 | - | - | Stock Option (Right to buy) | |
| Super Micro Computer | Charles Liang | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 80.92 per share. | 17 Jan 2023 | 12,201 | 6,706,072 (13%) | 0% | 80.9 | 987,340 | Common Stock |
| Super Micro Computer | Chiu-Chu Liu Liang | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 80.92 per share. | 17 Jan 2023 | 12,201 | 6,706,072 (13%) | 0% | 80.9 | 987,340 | Common Stock |
| Greif Inc (Class A) | Peter G. Watson | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 17 Jan 2023 | 12,133 | 244,830 (0%) | 0% | 0 | Class A Common Stock | |
| Ribbon Communications Inc | Bruns H. Grayson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 12,096 | 405,394 (0%) | 0% | - | Common Stock | |
| Shoals Tech Grp Inc (Class A) | Jason Whitaker | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 28.58 per share. | 17 Jan 2023 | 12,054 | 543,180 | - | 28.6 | 344,556 | Class A Common Stock |
| Shoals Tech Grp Inc (Class A) | Jason Whitaker | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 28.81 per share. | 17 Jan 2023 | 12,032 | 531,148 | - | 28.8 | 346,640 | Class A Common Stock |
| Bank of New York Mellon | Robin A. Vince | President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.68 per share. | 17 Jan 2023 | 11,882 | 100,713 (0%) | 0% | 49.7 | 590,298 | Common Stock |
| FirstCash Holdings Inc | Douglas R. Rippel | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 88.77 per share. | 17 Jan 2023 | 11,643 | 7,429,403 (17%) | 0% | 88.8 | 1,033,549 | Common Stock |
| JPMC | Elena A. Korablina | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 11,576 | 20,398 | - | - | Restricted Stock Units | |
| Iovance Biotherapeutics Inc | Igor Bilinsky | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 11,248 | 22,502 | - | - | Restricted Stock Units | |
| Iovance Biotherapeutics Inc | Igor Bilinsky | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 11,248 | 29,049 (0%) | 0% | 0 | Common Stock | |
| Iovance Biotherapeutics Inc | Finckenstein Friedrich Graf | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 11,248 | 32,796 (0%) | 0% | 0 | Common Stock | |
| Iovance Biotherapeutics Inc | Finckenstein Friedrich Graf | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 11,248 | 22,502 | - | - | Restricted Stock Units | |
| Treace Medical Concepts Inc | Richard W. Mott | Director | Sale of securities on an exchange or to another person at price $ 26.00 per share. | 17 Jan 2023 | 11,014 | 1,250,000 | - | 26.0 | 286,377 | Common Stock |
| Cadence Design | Lip-Bu Tan | Director, Executive Chair | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Jan 2023 | 11,000 | 945,936 (0%) | 0% | 0 | Common Stock | |
| Super Micro Computer | Charles Liang | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 80.38 per share. | 17 Jan 2023 | 10,937 | 6,722,881 (13%) | 0% | 80.4 | 879,117 | Common Stock |
| Super Micro Computer | Chiu-Chu Liu Liang | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 80.38 per share. | 17 Jan 2023 | 10,937 | 6,722,881 (13%) | 0% | 80.4 | 879,117 | Common Stock |
| Super Micro Computer | Charles Liang | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 82.79 per share. | 17 Jan 2023 | 10,825 | 6,681,919 (13%) | 0% | 82.8 | 896,174 | Common Stock |
| Super Micro Computer | Chiu-Chu Liu Liang | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 82.79 per share. | 17 Jan 2023 | 10,825 | 6,681,919 (13%) | 0% | 82.8 | 896,174 | Common Stock |
| Prologis | Timothy D. Arndt | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 10,787 | 130,102 | - | - | LTIP Units | |
| Super Micro Computer | Charles Liang | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 84.04 per share. | 17 Jan 2023 | 10,679 | 6,671,240 (13%) | 0% | 84.0 | 897,476 | Common Stock |
| Super Micro Computer | Chiu-Chu Liu Liang | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 84.04 per share. | 17 Jan 2023 | 10,679 | 6,671,240 (13%) | 0% | 84.0 | 897,476 | Common Stock |
| Greif Inc (Class A) | Gary R. Martz | Executive VP & General Counsel | 17 Jan 2023 | 10,596 | 95,726 (0%) | 0% | 0 | Class A Common Stock | ||
| Prologis | Eugene Frederick Reilly | Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 10,507 | 643,734 | - | - | LTIP Units | |
| Cencora | Steven H. Collis | Director, Chairman, President & CEO | 17 Jan 2023 | 10,499 | 257,967 (0%) | 0% | 164.3 | 1,724,776 | Common Stock | |
| Cencora | Steven H. Collis | Director, Chairman, President & CEO | 17 Jan 2023 | 10,499 | 268,466 (0%) | 0% | 77.5 | 813,987 | Common Stock | |
| Cencora | Steven H. Collis | Director, Chairman, President & CEO | 17 Jan 2023 | 10,499 | 158,993 | - | - | Non-qualified Stock Option (Right to Buy) |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.